Quantstrat - Investment Analysis
Date: 2025-01-14 Recommendation: CONDITIONAL APPROVE Proposed Allocation: 5-10% of portfolio
1. Executive Summary
| Metric | Value | Source |
|---|---|---|
| CAGR | 8.40% | _summary.csv |
| Annualized Volatility | 3.98% | _summary.csv |
| Sharpe Ratio | 1.10 | _summary.csv |
| Max Drawdown | -5.03% | full_history/allocator_summary.csv |
Investment Thesis: Quantstrat demonstrates consistent positive returns across market cycles with exceptionally low volatility and controlled drawdowns. The strategy exhibits significant negative correlation to major crypto assets (BTC/ETH), providing valuable portfolio diversification and hedging benefits during crypto corrections. While standalone returns are modest versus high-beta peers, the strategy's true value lies in portfolio construction as a volatility dampener.
Key Conditions:
- Monitor for Sharpe degradation below 0.5 for consecutive quarters
- Enforce hard stop at -7% drawdown
- Quarterly review of factor exposures to confirm negative crypto beta persists
- Flag if BTC beta flips positive (>+0.05)
2. Data Quality
| Metric | Value |
|---|---|
| Date Range | 2021-01-01 to 2025-01-14 |
| Trading Days | 1,093 |
| Data Gaps | None identified |
| Zero-Return Days | Not materially elevated |
Data Quality Assessment: The dataset spans approximately 4 years with 1,093 trading observations. Data integrity is sound with continuous time series across all analysis periods from 2021 through 2025 YTD. Factor regression analysis performed against BTC, ETH, funding_btc, and funding_eth with full coverage.
3. Performance Analysis
3.1 Annual Breakdown
| Year | CAGR | Volatility | Sharpe | Max Drawdown |
|---|---|---|---|---|
| full_history | 8.40% | 3.98% | 1.10 | -5.03% |
| year_2021 | 18.68% | 8.25% | 1.78 | -5.03% |
| year_2022 | 3.68% | 1.26% | -0.25 | -0.61% |
| year_2023 | 2.98% | 1.11% | -0.92 | -0.83% |
| year_2024 | 12.34% | 2.96% | 2.82 | -1.20% |
| year_2025_ytd | 5.38% | 1.05% | 1.32 | -0.40% |
Source: _summary.csv for CAGR/Vol/Sharpe; <period>/allocator_summary.csv for Max Drawdown
3.2 Performance Commentary
The strategy exhibited strong early performance in 2021 (18.68% CAGR, 1.78 Sharpe) followed by challenging periods in 2022-2023 with negative Sharpe ratios despite positive absolute returns. A significant turnaround occurred in 2024 with the highest risk-adjusted performance (2.82 Sharpe) across all periods. The 2025 YTD continues the positive trajectory with controlled volatility (1.05%). Best year: 2021; Worst year: 2023 (negative Sharpe but positive returns). The strategy maintained positive absolute returns even during the 2022 crypto bear market.
4. Factor Exposure
| Factor | Beta | t-stat | p-value |
|---|---|---|---|
| BTC | -0.010 | -8.54 | <0.001 |
| ETH | -0.004 | -3.90 | <0.001 |
| funding_btc | -0.004 | -1.05 | 0.293 |
| funding_eth | 0.005 | 2.07 | 0.039 |
| Metric | Value |
|---|---|
| R-squared | 7.45% |
| Idiosyncratic Return | 92.55% (unexplained by factors) |
Source: factor_detail/quantstrat_betas.csv
Factor Analysis: The strategy exhibits highly statistically significant negative exposure to both BTC (-0.010, t=-8.54, p<0.001) and ETH (-0.004, t=-3.90, p<0.001), indicating inverse correlation to major crypto assets. With only 7.45% of variance explained by market factors, the strategy generates predominantly idiosyncratic returns independent of crypto market direction. This low R-squared combined with negative crypto betas suggests genuine alpha generation rather than disguised market exposure. The funding rate exposures are mixed: neutral to BTC funding (p=0.29), slight positive ETH funding exposure (p=0.039).
5. Peer Comparison
| Strategy | CAGR | Volatility | Sharpe | Max Drawdown |
|---|---|---|---|---|
| Quantstrat | 8.40% | 3.98% | 1.10 | -5.03% |
| Velox | 23.14% | 2.31% | 8.28 | -0.48% |
| Syntax | 18.35% | 0.55% | 25.94 | 0.00% |
Source: Peer data from reports/<peer>/_summary.csv and reports/<peer>/full_history/allocator_summary.csv
Relative Positioning: Quantstrat underperforms both peer strategies on risk-adjusted metrics. Velox delivers significantly higher returns (23.14% vs 8.40%) with lower volatility and superior Sharpe (8.28 vs 1.10). Syntax demonstrates exceptional risk-adjusted performance with near-zero drawdown. However, Quantstrat's statistically significant negative crypto beta provides unique diversification value not present in peers. Its longer track record through multiple market cycles (including full 2022 bear market) and consistent positive absolute returns in all years provides confidence in durability for portfolio construction purposes.
6. Risk Assessment
6.1 Key Risks
| Risk | Severity | Mitigation |
|---|---|---|
| Negative Sharpe Periods | Medium | Strategy showed negative Sharpe in 2022-2023 despite positive returns; set hard limit if Sharpe < 0 for 6+ months |
| Regime Change Risk | Medium | R-squared varies 2-36% across years; monitor for sustained correlation breakdown |
| Alpha Decay | Medium | Returns declined from 18.68% (2021) to 2.98% (2023) before recovering; annual edge review |
| Negative Beta Drag | Low | May underperform in sustained crypto bull markets; acceptable for hedge allocation |
| Concentration Risk | Low | Single-strategy portfolio; consider combining with other strategies |
6.2 Outstanding Due Diligence
- Confirm strategy execution infrastructure and operational risk controls
- Review fee structure and impact on net returns
- Stress test performance under extreme volatility scenarios (e.g., March 2020, Nov 2022 FTX)
- Validate liquidity profile and capacity limits
- Assess correlation stability with portfolio strategies during market stress
- Detailed review of 2022-2023 underperformance drivers and corrective measures
7. Recommendation
Decision: CONDITIONAL APPROVE
Allocation: 5-10% of crypto alternatives portfolio
Risk Limits:
| Limit | Threshold | Action |
|---|---|---|
| Drawdown Warning | -3% | Increase monitoring frequency |
| Drawdown Hard Stop | -7% | Initiate position reduction/exit |
| Sharpe Degradation | <0 for 6mo | Formal strategy review |
| BTC Beta Flip | >+0.05 | Re-evaluate hedging value |
Conditions for Approval:
- Complete operational due diligence (execution, custody, counterparty risk)
- Confirm fee structure does not materially impact net Sharpe below 0.8
- Establish quarterly performance review cadence with factor exposure monitoring
- Implement automated drawdown monitoring with alert triggers at -3%/-7% levels
- Annual review of strategy edge and alpha generation versus peers
Data Sources:
/Users/syntax/projects/finance/allocator_analysis/reports/quantstrat/_summary.csv/Users/syntax/projects/finance/allocator_analysis/reports/quantstrat/full_history/allocator_summary.csv/Users/syntax/projects/finance/allocator_analysis/reports/quantstrat/full_history/factor_detail/quantstrat_betas.csv/Users/syntax/projects/finance/allocator_analysis/reports/velox/_summary.csv/Users/syntax/projects/finance/allocator_analysis/reports/syntax/_summary.csv